Missouri chapter of Alzheimer’s Association discusses new tool allowed to help fight against disease (LISTEN)

The FDA has approved the use of a blood test to determine if patients have a protein that is prevalent in Alzheimer’s disease.Alisa Nelson talks to Sarah Lovegreen, with the Greater Missouri chapter of the Alzheimer’s Association, who says the new tool is one step in helping to determine if someone has the disease.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.